Finance

Beta
Lists
003850:KRX
Boryung Corp
₩8,700.00
+3.57%
(+300.00) 1D
Jun 12, 3:30:26 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003850...
Open
₩8,530
High
₩8,800
Low
₩8,510
Mkt. cap
746.35B
Avg. vol.
150.29K
Volume
0.00
Dividend
1.84%
Quarterly dividend
₩40
Ex-dividend date
Dec 27, 2023
P/E ratio
6.93
52-wk high
₩10,800
52-wk low
₩7,910
EPS
₩1,255
Shares outstanding
85.79M
No. of employees
1K
Open
₩8,530
High
₩8,800
Low
₩8,510
Mkt. cap
746.35B
Avg. vol.
150.29K
Volume
0.00
Dividend
1.84%
Quarterly dividend
₩40
Ex-dividend date
Dec 27, 2023
P/E ratio
6.93
52-wk high
₩10,800
52-wk low
₩7,910
EPS
₩1,255
Shares outstanding
85.79M
No. of employees
1K
News stories
From sources across the web
About Boryung Corp
CEOJay Kim | Daniel Chang
Employees1.14K
FoundedOct 1, 1957
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
251.52B
280.01B
245.35B
255.35B
Cost of goods sold
154.20B
176.73B
160.45B
160.77B
Cost of revenue
154.20B
176.73B
160.45B
160.77B
Research and development expenses
14.14B
15.58B
19.29B
12.83B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.88B
52.15B
58.49B
54.69B
Operating expense
71.95B
73.85B
85.55B
74.43B
Total operating expenses
226.15B
250.57B
246.00B
235.20B
Operating income
25.37B
29.44B
-648.67M
20.15B
Other non operating income
-425.28M
-1.05B
-3.02B
-744.36M
EBT including unusual items
10.63B
43.46B
18.69B
53.93B
EBT excluding unusual items
2.60B
41.80B
3.23B
47.06B
Income tax expense
1.77B
9.46B
-2.40B
12.49B
Effective tax rate
16.62%
21.77%
-12.82%
23.16%
Other operating expenses
951.78M
1.06B
2.82B
1.97B
Net income
8.86B
34.00B
21.09B
41.44B
Net profit margin
3.52%
12.14%
8.60%
16.23%
Earnings per share
-
-
-
-
Interest and investment income
1.73B
3.47B
1.88B
5.07B
Interest expense
-2.60B
-3.03B
-4.14B
-2.97B
Net interest expenses
-868.66M
446.84M
-2.26B
2.10B
Depreciation and amortization charges
491.90M
474.75M
409.64M
390.19M
EBITDA
35.85B
40.76B
10.58B
31.34B
Gain or loss from assets sale
-4.46M
-2.95M
-22.08M
-7.23B
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more